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Activation of the host gene egr1 is essential for the lytic replication of Epstein–Barr virus (EBV).
egr1 is activated by Zta (BZLF1, ZEBRA). Zta interacts directly with DNA through a series of
closely related Zta-response elements (ZREs). Here we dissect the mechanism used by Zta to
interact with the egr1 promoter and identify a weak interaction with egr1ZRE that is dependent on
the distal part of egr1ZRE. Furthermore, we demonstrate that the ability of Zta to interact with
egr1ZRE is enhanced at least tenfold by methylation. The ability of Zta to transactivate a reporter
construct driven by the egr1 promoter can be enhanced by methylation. As the ability of Zta to
interact with a methylated ZRE in the EBV genome correlates with its ability to activate the
expression of the endogenous viral gene BRLF1, this suggests that Zta may also have the
capability to overturn epigenetic control of egr1.
Following infection, Epstein–Barr virus (EBV) establishes
long-lived latency in memory B-lymphocytes (Thorley-
Lawson et al., 1996) and other lineages (Chaganti et al.,
2008; Conacher et al., 2005). Reactivation from latency can
occur from both memory B-lymphocytes and tumour cells,
induced by a variety of physiological stimuli (Miller, 1989).
The key regulator of EBV lytic replication, Zta (BZLF1, Zta,
ZEBRA) is a virally encoded transcription and replication
factor which interacts directly with DNA through its basic
region both in Zta-regulated promoters and within the
origin of lytic replication (Feederle et al., 2000; Miller et al.,
2007; Sinclair, 2003, 2006; Sinclair & Farrell, 1992; Speck
et al., 1997). Zta also interacts indirectly with DNA and has
the potential to alter gene expression through its interac-
tions with some host transcription factors (Gutsch et al.,
1994; Sista et al., 1993, 1995; Swenson et al., 2001; Wu et al.,
2003; Zhang et al., 1994).
Zta interacts with a subset of ZREs that contain CpG
motifs (Bhende et al., 2004). Methylation of transcription
factor binding sites at CpG motifs is normally either
inhibitory for binding (BSAP, ATF, YY1, EPO80) or
neutral (SP1, RFX) (Falzon & Kuff, 1991; Holler et al.,
1988; Iguchi-Ariga & Schaffner, 1989; Mancini et al., 1998;
Tierney et al., 2000). Methylated DNA is generally
associated with non-expressed genes and the inability of
some transcription factors to interact with methylated
DNA may play a role in either silencing, or maintaining the
inhibition of, gene expression. In contrast, Zta has the
unusual property of displaying enhanced binding to
methylated ZREs (Bhende et al., 2004, 2005; Karlsson
et al., 2008a, b; Petosa et al., 2006; Wang et al., 2005).
The host gene egr1 encodes a transcription factor which is
induced following EBV lytic cycle activation, through the
action of Zta (Chang et al., 2006). egr1 is involved in
diverse biological functions (Sukhatme et al., 1988).
Mutational analysis of the promoter suggests that activa-
tion by Zta occurs through a serum response element
(SRE) that is flanked by two Ets response elements and
through a tandem pair of potential ZREs (Fig. 1). Zta
activates Erk, a member of the MAP kinase family,
resulting in transactivation through the Ets response
elements (Chang et al., 2006). Indeed, mutation of either
the Ets or ZRE sites impacts upon Zta activation in vivo
(Chang et al., 2006), suggesting that both direct and
indirect mechanisms are used to activate expression
through Zta.
The egr1 promoter contains tandem copies of potential
ZREs. A mutation covering both sites was shown to
decrease Zta transactivation in vivo (Chang et al., 2006);
however, the precise sequence elements required for Zta to
interact with the egr1 promoter have not been mapped. In
order to investigate the molecular mechanism by which Zta
can directly activate egr1 expression, we questioned the
contribution from each ZRE for the interaction with Zta.
A schematic diagram of the egr1 promoter region is shown
in Fig. 1. The ability of Zta to interact with the egr1ZRE
was assessed using electrophoretic mobility shift assays
(EMSA). A Zta–DNA complex was readily detected
A supplementary figure showing the effect of methylation and Zta
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EBV BRLF1 promoter (RpZRE2) (Fig. 1c). The presence of
a Zta complex with the egr1ZRE probe, which spans both
ZREs, was difficult to detect in comparison, although long
exposures revealed a weak protein–DNA complex. From
titration experiments we demonstrate that Zta forms a
complex with the egr1ZRE probe that is at least 20-fold
weaker than that formed with three examples of previously
characterized ZREs: RpZRE2, RpZRE1 and AP1 (Fig. 1d).
The individual mutations of the tandem ZRE sequences
reveal that both contribute to complex formation (Fig. 1c);
mutation of the proximal site results in a modest reduction
in binding, whereas mutation of the distal site ablates Zta
complex formation under these conditions.
Intriguingly, the distal egr1ZRE contains a CpG motif (Fig.
2a). Zta has the unusual property of being able to recognize
response elements when methylated at CpG motifs; indeed,
the interaction between Zta and two previously character-
ized ZREs from the BRLF1 promoter, RpZRE2 and
RpZRE3, is strongly enhanced by methylation (Bhende et
al., 2004, 2005; Karlsson et al., 2008b). egr1 is methylated in
B-cells, yet a combination of demethylation agents and
physiological stimuli is able to induce egr1 expression
(Seyfert et al., 1990). This demonstrates that methylation
can play a role in the control of egr1 gene expression.
To assess whether methylation has any effect on the interaction
between Zta and the egr1ZRE, we generated unmethylated and
methylated egr1ZRE probes and assessed the interaction of
each with Zta by EMSA (Fig. 2). Methylation of the single CpG
motif in the distal ZRE clearly enhanced DNA binding and
titration experiments revealed that at least tenfold more Zta–
DNA complex is formed with the methylated egr1ZRE
compared with the unmethylated egr1ZRE.
Molecular modelling predicts that the methylated cytosines
of RpZRE2 and RpZRE3 make contact with Zta amino acid
residues S186, C189 and R190 as indicated in Fig. 3
(Bhende et al., 2005; Karlsson et al., 2008a; Petosa et al.,
2006). Indeed, S186 and C189 have been shown to aid
binding to methylated RpZRE2 and RpZRE3 experiment-
ally (Bhende et al., 2005; Karlsson et al., 2008a, b; Wang et
al., 2005). In addition to their relevance for interaction
with methylated ZREs, mutations of C189 and S186
promote differential binding to some non-CpG-containing
ZREs (summarized by Heston et al., 2006).
Fig. 1. Interaction of Zta with egr1ZREs. (a) The organization of
the egr1 promoter is shown schematically. The numbers represent
distance from the transcription initiation site. The Ets response
elements are shown by filled boxes, with the SRE hatched. The
open boxes represent the tandem ZREs, proximal (p) and distal (d).
(b) The nucleotide sequence of one strand of the oligonucleotide
spanning the ZREs is shown. egr1 represents the wild-type
sequence, egr1 dZRE mut, the mutation in the distal ZRE and egr1
pZRE mut, the mutation in the proximal ZRE. Double-strand
versions of these sequences were used as probes for EMSA. (c)
EMSA analysis of the interaction between Zta and egr1, egr1
pZRE mut, egr1 dZREmut and RpZRE2 was undertaken as
described previously (Schelcher et al., 2005, 2007). Probes were
labelled to approximately equivalent specific activities and the
relative amounts used in the reactions are: egr1 (1.0), egr1 pZRE
mut (0.5), egr1 dZRE mut (0.7) and RpZRE2 (0.3). In these
experiments the probe is in excess, as shown by the dose
response in (d) and (e). Zta protein was generated in a wheatgerm
translation system, and its interaction with a labelled probe was
compared with an unprogrammed lysate as control. For each
panel, complexes were separated on the same gel by electro-
phoresis and visualized by phosphoimaging. The exposure of the
bottom panel was ten times longer than that shown in the top panel
to visualize the weak Zta–egr1 protein–DNA complexes. The
experiment was repeated with similar results. (d) EMSA analysis of
the interaction between Zta and egr1, compared with known strong
ZREs, RpZRE1 (GATCTCTTTTATGAGCCATTGGCA), RpZRE2
(GATCAAGCTTATGAGCGATTTTTAT) (Bhende et al., 2004) and
AP1 (GATCCATGACTCAGAGGAAAACATACG) (Hicks et al.,
2003; Kouzarides et al., 1991), were undertaken as in (c). The
relative amounts of probes used in the reactions are equivalent. The
experiment was repeatedwithsimilarresults.(e) Quantificationofthe
complexes for RpZRE1 and egr1. These were detected by
phosphoimaging in two experiments. Error bars indicate SD.
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homology with RpZRE2 (6/7 of the heptad core), and
significant homology with RpZRE3 (4/7 of the heptad
core), suggesting that the same amino acid residues may
contribute to interaction with the methylated CpG motif.
As only the rightwards CpG motif of RpZRE3 is conserved
within the distal egr1ZRE, it is relevant to question the
contribution of amino acids C189 and S186 to the DNA-
binding function. To assess this, we used single point
mutants of Zta, ZtaC189A and ZtaS186A, to investigate
their impact on the interaction of Zta with methylated
egr1ZRE. The full-length version of each protein was
generated in an in vitro translation system (Fig. 3) and the
interaction of equivalent amounts of each with methylated
egr1ZRE probe was analysed by EMSA. Mutation of either
S186 or C189 greatly reduced the ability of Zta to interact
with the methylated egr1ZRE.
To assess whether methylation of the egr1 promoter affects
the ability of Zta to activate it, we co-expressed Zta and a
previously characterized egr1 promoter construct (Chang et
al., 2006) in two epithelial cell lines. A comparison was
undertaken between methylated and non-methylated ver-
sions of the promoter construct (Fig. 3e). In HeLa cells, Zta
did not activate expression of the untreated plasmid, yet
Zta activated the methylated reporter construct approxi-
mately fourfold. This clearly demonstrates that Zta can
preferentially activate the methylated egr1 promoter
construct.
We note that the Zta activation occurs against a
background of decreased Zta-induced activity of the egr1
promoter plasmid that had undergone a ‘mock-methyla-
tion’ reaction. We also noticed a reduction in the basal
activity of plasmids that have been methylated and a partial
reduction in basal activity of those plasmids that have been
through the mock-methylation reaction in all cell types
tested (data not shown). This mirrors what has been
described previously for the BRLF1 and BZLF1 promoters
in 293T and DG75 cells (Bhende et al., 2004, 2005).
In contrast, in U2OS cells, Zta activation of expression of
the egr1 promoter plasmid was approximately twofold for
both the untreated and the methylated plasmids, suggesting
no methylation-dependent enhancement (Supplementary
Fig. S1, available in JGV Online). This analysis suggests that
the enhanced activation by Zta from the methylated egr1
promoter is cell-line dependent.
Fig. 2. Interaction of Zta with methylated egr1ZRE. (a) The
nucleotide sequence of one strand of the oligonucleotide spanning
the ZREs is shown, together with the methylated version (under-
lined). Double-strand versions of these sequences were used as
probes in EMSA. (b) EMSA analysis of the indicated proteins with
the egr1 probes was carried out as described in Fig. 1. Probes
were labelled to approximately equivalent specific activities and the
relative amounts used in each comparison are egr1 (1.0) and
egr1meth (0.72). The experiment was repeated with similar results.
(c) EMSA analysis of the interaction between Zta and egr1,
compared with the methylated egr1 was undertaken using serial
dilutions of Zta protein. The experiment was repeated with similar
results. (d) Quantification of the complexes for egr1meth and egr1
(density units10
”6) after adjustment for the relative amounts of
probes used for each EMSA. These were detected by phospho-
imaging in two experiments. Error bars indicate SD.
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with the egr1ZRE through the distal ZRE and furthermore
that methylation of the CpG motif in the distal element
does not prevent the interaction with Zta, but rather
enhances binding. The methylation sensitivity of the
interaction of Zta with egr1ZRE and the dependence on
S186 and C189 resembles its binding with RpZRE3
(Karlsson et al., 2008a, b). The BRLF1 promoter is
methylated during viral latency (Bhende et al., 2005) and
the ability of Zta to interact with methylated RpZRE3
correlates with its ability to activate expression of BRLF1 in
a B-cell line (Karlsson et al., 2008a, b). The demonstration
that activation of the egr1 promoter by Zta can be
enhanced by methylation suggests that Zta may be able
to activate the egr1 promoter in vivo, when it is methylated.
Thus the potential arises that Zta is able to overturn the
epigenetic silencing of both a viral promoter (BRLF1) and a
host promoter (egr1).
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